Centessa Pharmaceuticals
IPOPublic · United States · $550.0M raised
- Website
- centessa.com
- Total Funding
- $550.0M
- Last Round
- $300.0M Corporate RoundApr 2024
- Rounds
- 2
- Type
- Public
About
Centessa Pharmaceuticals is a next-gen biopharmaceutical company reshaping traditional drug development with its asset-centric R&D model.
Summary
Centessa Pharmaceuticals is a Healthcare company based in United States. It has raised $550.0M in total across 2 rounds, most recently a $300.0M Corporate Round round in Apr 2024. Investors include General Atlantic and EcoR1 Capital.
Tech & App Stack
6 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Health insurance company using technology to make health care simple, affordable, and accessible.
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...